Revolution Beauty Group (REVB) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
2 Dec, 2025Executive summary
Revenue for H1 FY26 declined 31.8% year-over-year to £49.4m, reflecting ongoing operational and strategic challenges from prior periods.
Gross margin remained stable at 32.2%, but profitability was impacted by clearance sales and cost pressures.
Operating loss widened to £16.7m from £9.8m in H1 FY25, with adjusted EBITDA loss at £12.5m versus £6.3m prior year.
Founders returned post-period, leading to renewed leadership, a successful £16.5m equity raise, and refinancing.
Early H2 trading shows a return to EBITDA profitability and retail sales growth in key markets.
Financial highlights
Revenue: £49.4m (down 31.8% year-over-year).
Gross profit: £15.9m (down 31.5% year-over-year).
Gross margin: 32.2% (vs. 32.0% prior year).
Adjusted EBITDA: loss of £12.5m (vs. £6.3m loss prior year).
Loss before tax: £18.4m (vs. £10.9m loss prior year).
Cash at period end: £1.8m; net debt: £30.2m.
Outlook and guidance
H2 has seen a return to retail sales growth and EBITDA profitability.
Full-year sales and adjusted EBITDA will not meet previous guidance due to H1 underperformance.
Adjusted EBITDA run rate expected to reach £8-10m by end of FY26, with H2 FY26 outturn around £4m.
Management expects a cash inflow in H2 from seasonal working capital unwind.
Latest events from Revolution Beauty Group
- Revenue down 25% to £142.6m, loss before tax £16.8m, with major restructuring and new financing.REVB
H2 202520 Feb 2026 - Profitability restored with higher margins; H2 FY 2025 growth expected after strategic reset.REVB
H2 20243 Feb 2026 - Underlying EBITDA rose 18% to £3.9m despite a 20% revenue drop; growth expected in Q4.REVB
H1 202513 Jan 2026 - Revenue dropped 26% in FY25, but new launches and brand gains support future growth.REVB
Trading Update7 Jul 2025 - FY25 sales to fall 25%, but core growth and new launches set up FY26 recovery.REVB
Trading Update6 Jun 2025